| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.09 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.48 | 0.09 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.084 | 0.1 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |